MedPath

Early Phase Clinical Trial to Test the Feasibility of an ACT-based Physical Activity Promotion Program for Adults with Depressive Symptoms

Not Applicable
Active, not recruiting
Conditions
Physical Inactivity
Registration Number
NCT05407935
Lead Sponsor
Brown University
Brief Summary

The goal of the proposed project is to conduct a feasibility clinical trial comparing group-based acceptance and commitment therapy for physical activity, (ACT; ACTivity) to a time- and attention-matched standard PA intervention (i.e., PA education, goal-setting, and self-monitoring) plus relaxation training comparison condition (Relaxercise) among 60 low-active adults (ages 18-65) with elevated depressive symptoms. Participants will be randomized to treatment condition, followed for 6 months, including the 8-week treatment. Participants will be randomized 1:1 to treatment condition, followed for 6 months, including the 8-week treatment, and receive a 6-month YMCA membership to equate access to PA facilities.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Elevated depressive symptoms (CES-D score of greater than or equal to 10)
  • Low-active (less than 60 minutes per week of moderate intensity PA)
  • Willing and able to attend weekly virtual video sessions via Zoom
Exclusion Criteria
  • Regular mindfulness meditation practice (more than once per week)
  • Body Mass Index (BMI) less than 18.5 or greater than 40
  • History or presence of any condition that may limit or substantially increase the risks of physical activity
  • Active suicidal thoughts or behaviors
  • Currently participating in any exercise or weight-loss research studies
  • Household member is participating in this study
  • Does not have a Rhode Island mailing address OR if only Rhode Island mailing address is a PO box
  • Unable to receive materials in the mail at residential mailing address
  • Does not plan to live in Rhode Island for the next 6 months
  • Unable to speak, read, and/or write fluently in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in AccelerometryBaseline, Post-Treatment (8 weeks), 6-months

Minutes of physical activity weighted by intensity, expressed in metabolic equivalent (MET) minutes per week as determined by accelerometers (Actigraph \[model wGT3x-BT\]) worn during one-week periods.

Secondary Outcome Measures
NameTimeMethod
Change in Self-report physical activity (Godin)Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months

Self-reported minutes of leisure time physical activity per week weighted by intensity

Change in Self-reported depression symptoms (CES-D)Baseline, Mid-Treatment (4 weeks) Post-Treatment (8 weeks), 6-months

Score on the Center for Epidemiological Studies Depression Scale (CES-D)

Trial Locations

Locations (1)

Brown University

🇺🇸

Providence, Rhode Island, United States

Brown University
🇺🇸Providence, Rhode Island, United States
© Copyright 2025. All Rights Reserved by MedPath